Post-IPO Equity Biotechnology Companies

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Harvard Apparatus Regenerative Technology is a biotechnology firm developing esophageal implants for patients battling threatening condition

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

Estrella Immunopharma develops transformative cancer medicines with CD19-Redirected ARTEMIS T Cells to improve patients’ lives.

Intelligent Bio Solutions leverages the power of technology to develop transformative, accurate solutions that improve quality of life.

Adaptin Bio is a pioneering biotechnology business focused to transforming medicine delivery.

Chimeric Therapeutics is a company developing ground-breaking CAR T cell therapies for solid tumors.

IN8Bio is a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer.

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.

Tivic Health is a commercial health tech company that develops bioelectronic medicine to alleviate symptoms of inflammatory conditions.

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.

Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

CRISM Therapeutics is a pharmaceutical company that develops ChemoSeed to improve the clinical performance of cancer treatments.

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Inify Laboratories provides cancer diagnostics through ultra-modern laboratory services within pathology.

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.